- Home
- SLE vs RDHL Comparison
SLE vs RDHL Comparison
Compare SLE & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLE
- RDHL
- Stock Information
- Founded
- SLE 2014
- RDHL 2009
- Country
- SLE United States
- RDHL Israel
- Employees
- SLE N/A
- RDHL N/A
- Industry
- SLE Services-Misc. Amusement & Recreation
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- SLE Consumer Discretionary
- RDHL Health Care
- Exchange
- SLE Nasdaq
- RDHL Nasdaq
- Market Cap
- SLE 3.6M
- RDHL 3.9M
- IPO Year
- SLE 2019
- RDHL N/A
- Fundamental
- Price
- SLE $4.04
- RDHL $1.70
- Analyst Decision
- SLE Strong Buy
- RDHL
- Analyst Count
- SLE 2
- RDHL 0
- Target Price
- SLE $100.00
- RDHL N/A
- AVG Volume (30 Days)
- SLE 51.3K
- RDHL 43.1K
- Earning Date
- SLE 11-13-2025
- RDHL 09-05-2025
- Dividend Yield
- SLE N/A
- RDHL N/A
- EPS Growth
- SLE N/A
- RDHL N/A
- EPS
- SLE N/A
- RDHL N/A
- Revenue
- SLE $13,576,000.00
- RDHL $9,550,000.00
- Revenue This Year
- SLE N/A
- RDHL $381.91
- Revenue Next Year
- SLE $30.36
- RDHL N/A
- P/E Ratio
- SLE N/A
- RDHL N/A
- Revenue Growth
- SLE N/A
- RDHL 157.62
- 52 Week Low
- SLE $2.75
- RDHL $1.06
- 52 Week High
- SLE $45.60
- RDHL $11.70
- Technical
- Relative Strength Index (RSI)
- SLE 60.99
- RDHL 63.39
- Support Level
- SLE $2.89
- RDHL $1.47
- Resistance Level
- SLE $3.25
- RDHL $1.60
- Average True Range (ATR)
- SLE 0.30
- RDHL 0.09
- MACD
- SLE 0.12
- RDHL 0.04
- Stochastic Oscillator
- SLE 88.36
- RDHL 97.98
About SLE Super League Enterprise Inc.
Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.